SmallCap
CompaniesMapStatistics

(주)미래생명자원

Listed
Venture Certified
Data Quality: 95/10

Basic Information


Listed

Stock Code: 218150

Company Name(주)미래생명자원
English NameMILAE BIORESOURCES CO., LTD.
Business Reg. No.4928800056
CEO김성진
Address서울특별시 송파구 법원로9길 26 D동 506 ~ 512호(문정동, H business PARK)
Industry단미 사료 및 기타 사료 제조업
Industry Code109
Established2015-04-06
Phone02-2203-7397
Websitewww.milaebio.com
Regular Employees12persons
Corp. Reg. No.1101115687615

Investment Metrics


Market Cap
-
Op. Margin
1.21%
ROE
-0.23%
Debt Ratio
7.17%

Certification Status


Venture Certified

Cert. History
기술평가보증기업(기금)2014-11-17 ~ 2016-11-1620140112174-
기술평가보증기업(기금)2016-11-17 ~ 2018-11-1620160113014-
기술평가보증기업(기금)2018-02-13 ~ 2020-02-12201801013802018-02-13
기술평가보증기업(기금)2020-02-13 ~ 2022-02-12202001011442018-02-13
혁신성장유형2022-02-13 ~ 2025-02-12202201270303192018-02-13
혁신성장유형2025-02-13 ~ 2028-02-12202502260300692018-02-13

Financial Statements


3-Year Financial Data

Revenue CAGR -0.7%

Item202420232022
Revenue

473B

457B

479B

Operating Profit

5.7B

7.2B

19B

Net Profit

-1.0B

10B

9.6B

Total Assets

477B

479B

521B

Total Liabilities

32B

33B

113B

Total Equity

445B

446B

408B

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
473B

1.0%

vs. 3-Year Avg.: 468B
Operating Profit
6B

56.2%

vs. 3-Year Avg.: 13B
Op. Margin
1.2%

56.2%

vs. 3-Year Avg.: 2.8%
Debt Ratio
7.2%

59.0%

vs. 3-Year Avg.: 17.5%
ROE
-0.2%

110.2%

vs. 3-Year Avg.: 2.3%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
김성진대표이사대표

Employment Status


NPS Subscribers

12persons

CEO김성진
Est. Avg. Annual Salary

4,42410K

(36910K/mo)
Based on NPS rate 9.5%
Hired (12 mo)

+0persons

Left (12 mo)

-1persons

Net Change (12 mo)

-1persons

NPS Join Date

2017-12-11

Monthly Employee Trend
Hired
Left

Patent Status

Updated: 2026-02-25

5 Patents
4 Registered
2 in 3 Years
A23 식품/식료품 (14)
A61 의학/수의학/위생 (11)
C07 유기화학 (1)
Patent TitleApplicantApplication No.Filing DateStatus
더덕, 삼백초, 길경 및 프로폴리스를 유효성분으로 포함하는 호흡기 질환의 예방. 개선 또는 치료를 위한 조성물주식회사 미래생명자원10202401445562024-10-22등록
테트라셀미스 츄이로부터 분리한 신규 화합물 및 이의 용도주식회사 미래생명자원|충남대학교산학협력단10202301945352023-12-28등록
탕세노사이드(Tangshenoside) I을 유효성분으로 함유하는 근육 질환의 예방 또는 치료용 약학적 조성물주식회사 미래생명자원|정우재10202101520112021-11-08등록
글루코라파닌 함량이 증진된 브로콜리 분말의 제조방법주식회사 미래생명자원10202100921242021-07-14등록
식품의 초고압 살균 처리 방법주식회사 미래생명자원10202100412802021-03-30거절

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status

Updated: 2026-03-05

Venture

Other Public Data


2 Additional Data Sources

{
  "address": "경기도 이천시 호법면 덕평로",
  "brno": "469850****",
  "cappedWarning": false,
  "companyName": "(주)미래생명자원이천공장",
  "estimatedAvgAnnualSalary": 44244420,
  "estimatedAvgMonthlySalary": 3687035,
  "fetchedAt": "2026-03-05T19:39:05.867Z",
  "industryCode": "153300",
  "industryName": "배합 사료 제조업",
  "joinDate": "20171211",
  "last12MonthsHired": 0,
  "last12MonthsLeft": 1,
  "last12MonthsNetChange": -1,
  "leaveDate": null,
  "monthlyPensionAmount": 4203220,
  "monthlyTrend": [
    {
      "lostSubscribers": 1,
      "newSubscribers": 0,
      "yearMonth": null
    }
  ],
  "npsRateUsed": 0.095,
  "npsUpperCap": 6370000,
  "seq": "6487392",
  "status": "1",
  "styleCode": "1",
  "subscriberCount": 12,
  "turnoverMonths": 1
}

{
  "address": "서울특별시 송파구",
  "ceo_name": "김성진",
  "certificate": [
    {
      "cert_number": "20140112174",
      "changes": "",
      "disclosure_date": "2014-11-17",
      "first_cert_date": "",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2014-11-17 ~ 2016-11-16"
    },
    {
      "cert_number": "20160113014",
      "changes": "",
      "disclosure_date": "2016-11-21",
      "first_cert_date": "",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2016-11-17 ~ 2018-11-16"
    },
    {
      "cert_number": "20180101380",
      "changes": "",
      "disclosure_date": "2018-02-13",
      "first_cert_date": "2018-02-13",
      "no": "3",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2018-02-13 ~ 2020-02-12"
    },
    {
      "cert_number": "20200101144",
      "changes": "",
      "disclosure_date": "2020-02-07",
      "first_cert_date": "2018-02-13",
      "no": "4",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2020-02-13 ~ 2022-02-12"
    },
    {
      "cert_number": "20220127030319",
      "changes": "",
      "disclosure_date": "2022-01-27",
      "first_cert_date": "2018-02-13",
      "no": "5",
      "type": "혁신성장유형",
      "valid_period": "2022-02-13 ~ 2025-02-12"
    },
    {
      "cert_number": "20250226030069",
      "changes": "",
      "disclosure_date": "2025-02-26",
      "first_cert_date": "2018-02-13",
      "no": "6",
      "type": "혁신성장유형",
      "valid_period": "2025-02-13 ~ 2028-02-12"
    }
  ],
  "company_name": "주식회사 미래생명자원",
  "financials": {
    "2022": {
      "capital_stock": 1989584000,
      "cost_of_sales": 39965070000,
      "current_assets": 38468780000,
      "current_liabilities": 11090024000,
      "gross_profit": 7949208000,
      "net_income": 959643000,
      "net_income_bs": 893827000,
      "non_current_assets": 13582176000,
      "non_current_liabilities": 175026000,
      "non_operating_expenses": 1393831000,
      "non_operating_income": 462059000,
      "operating_profit": 1891415000,
      "revenue": 47914278000,
      "sga_expenses": 6057793000,
      "total_assets": 52050956000,
      "total_equity": 40785906000,
      "total_liabilities": 11265050000
    },
    "2023": {
      "capital_stock": 2041580000,
      "cost_of_sales": 38759815000,
      "current_assets": 35132915000,
      "current_liabilities": 3130917000,
      "gross_profit": 6923293000,
      "net_income": 1011859000,
      "net_income_bs": 907297000,
      "non_current_assets": 12791068000,
      "non_current_liabilities": 147050000,
      "non_operating_expenses": 928749000,
      "non_operating_income": 1220821000,
      "operating_profit": 719787000,
      "revenue": 45683108000,
      "sga_expenses": 6203506000,
      "total_assets": 47923983000,
      "total_equity": 44646016000,
      "total_liabilities": 3277967000
    },
    "2024": {
      "capital_stock": 2041580000,
      "cost_of_sales": 40818177000,
      "current_assets": 22978167000,
      "current_liabilities": 3082113000,
      "gross_profit": 6438525000,
      "net_income": -104478000,
      "net_income_bs": -134230000,
      "non_current_assets": 24714149000,
      "non_current_liabilities": 107577000,
      "non_operating_expenses": 1505285000,
      "non_operating_income": 828711000,
      "operating_profit": 572096000,
      "revenue": 47256702000,
      "sga_expenses": 5866429000,
      "total_assets": 47692316000,
      "total_equity": 44502626000,
      "total_liabilities": 3189690000
    }
  },
  "industry": "단미 사료 및 기타 사료 제조업",
  "investment": [],
  "phone": "02-2203-****",
  "source": "pg_migration"
}

Data Sources


Data Quality: 95/10 | Primary Source: DART | Section Coverage: 8/8

Data Sources by Section
SectionSource:Status
Basic InfoDART
Collected
Financial StatementsVenture System
Collected
Investment MetricsVenture System
Collected
OfficersDART
Collected
EmploymentPublic Data
Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
nps2026-03-05
Collected
Venture System Detail2026-03-05
Collected
SME Status Info2026-03-05
Collected
DART Financial2026-02-26
Collected
G2B Procurement2026-02-25
Collected
Employment Insurance2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Cert. Info2026-02-25
Collected